Home › Glioma › New Jersey
Glioma clinical trials in New Jersey
11 studies for Glioma are looking for participants at sites in New Jersey.
Cities in New Jersey
A Study of Mirdametinib in People With Central Nervous System Tumors
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07539441Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
- Rutgers Cancer Institute, New Brunswick
- Atlantic Health, Summit
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07326566Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- Rutgers Cancer Institute, New Brunswick
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07703436SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Rutgers Cancer Institute, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.
- Cooper University HealthCare, Camden
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Oct 9, 2026 · NCT07439172Glioma Developmental and HyperActive Ras Tumor (DHART) Board
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05489783Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 1 to 25 · All sexes · Updated Aug 18, 2026 · NCT04485559A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT05188508A Study of 177Lu-PSMA-617 in People With Gliomas
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT07223034Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors
- Hackensack Meridian Health, Inc, Edison
RecruitingPhase 1/2
Up to age 18 · All sexes · Updated Nov 20, 2025 · NCT04299191From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.